Welcome to The Oncology Expert Exchange. This freely accessible resource provides a range of CE activities across the spectrum of oncology and hematology/oncology conditions. Our goal is to ensure that you – the practicing clinician – have the most accurate, up-to-date information on the diagnosis, management, and treatment strategies for solid and hematological malignancies.
We encourage you to share this educational resource with your colleagues and your healthcare team.
Displaying 9 courses
Acute Myeloid Leukemia (1 course)
Optimizing Outcomes for AML Patients Ineligible for Intensive Therapy: Individualizing Treatment Selection and Management
Disease State: Acute Myeloid Leukemia
Expiration Date: Aug. 21, 2024
Multiple Myeloma (1 course)
Transforming Progress Into Action in Relapsed/Refractory Multiple Myeloma: Improving Patient Outcomes Through Innovative Bispecific Antibodies
Disease State: Multiple Myeloma
Expiration Date: Jun. 17, 2025
Acute Lymphoblastic Leukemia (1 course)
Improving Outcomes for Adolescent/Young Adult and Adult Patients with ALL: Evaluating the Impact of Immunotherapy
Disease State: Acute Lymphoblastic Leukemia
Expiration Date: Dec. 12, 2023
Breast Cancer (6 courses)
Overcoming Mechanisms of Resistance in HR+/HER2- Advanced Breast Cancer: Exploring AKT Inhibitors, Oral SERDs, and Other New Therapy Classes
Disease State: Breast Cancer
Expiration Date: Dec. 22, 2024
The Nurse’s Role in Care Coordination and Multidisciplinary Care for HR+/HER2 – EBC
Disease State: Breast Cancer
Expiration Date: Nov. 28, 2023
Engaging Patients in Care: Strategies for Shared Decision-making and Patient Education
Disease State: Breast Cancer
Expiration Date: Nov. 28, 2023
Nurse-led Strategies to Overcome Barriers to Adherence and Persistence to Oral Therapies in HR+/HER2- EBC
Disease State: Breast Cancer
Expiration Date: Nov. 28, 2023
Adverse Event Management of Oral Therapies in HR+/HER2- EBC
Disease State: Breast Cancer
Expiration Date: Nov. 28, 2023
CDK4/6 Inhibitors in HR+/HER2-EBC: Updates in Adjuvant Therapy Paradigms for High Risk Disease
Disease State: Breast Cancer
Expiration Date: Nov. 28, 2023
Hematological Malignancies (3 courses)
Improving Outcomes for Adolescent/Young Adult and Adult Patients with ALL: Evaluating the Impact of Immunotherapy
Disease State: Acute Lymphoblastic Leukemia
Expiration Date: Dec. 12, 2023
Optimizing Outcomes for AML Patients Ineligible for Intensive Therapy: Individualizing Treatment Selection and Management
Disease State: Acute Myeloid Leukemia
Expiration Date: Aug. 21, 2024
Transforming Progress Into Action in Relapsed/Refractory Multiple Myeloma: Improving Patient Outcomes Through Innovative Bispecific Antibodies
Disease State: Multiple Myeloma
Expiration Date: Jun. 17, 2025